Polypharmacy in patients with multiple sclerosis and the impact on levels of care and therapy units

BackgroundThe aim of this study was to examine the societal costs of polypharmacy in patients with multiple sclerosis (MS). We therefore focused on the association between the number of medications on the level of care (LOC), the German classification of the need for care, and the number of therapy...

Full description

Bibliographic Details

Published in:	Frontiers in Neurology
Main Authors:	Finn Brüggemann, Stefan Gross, Marie Süße, Pavel Hok, Sebastian Strauss, Tjalf Ziemssen, Niklas Frahm, Uwe K. Zettl, Matthias Grothe
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Subjects:	multiple sclerosis polypharmacy health costs level of care comorbidity
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1330066/full